PSC
ACLS icon

Piper Sandler & Co’s Axcelis ACLS Stock Holding History

Piper Sandler & Co’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,250
Closed -$67K – 30
2015
Q3 		$67K Sell
6,250
-18,750
-75% -$228K 0.07% 93
2015
Q2 		$296K Buy
+25,000
New +$290K 0.18% 66

Other funds holding ACLS

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Piper Sandler & Co's ACLS Position: Q4 2015 in Review

Piper Sandler & Co sold out of Axcelis (ACLS) in Q4 2015, closing a stake of 6,250 shares — an estimated $67K sold.

Piper Sandler & Co first reported a position in ACLS in Q2 2015 and held it in 2 quarters. The position peaked at $296K in Q2 2015. 112 funds tracked by Wall St. Rank hold ACLS as of Q4 2015.

  • Piper Sandler & Co reported no remaining Axcelis position as of Q4 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 6,250 Axcelis shares in Q4 2015, an estimated $67K.
  • Piper Sandler & Co first reported a position in Axcelis in Q2 2015 and held it in 2 quarters.
  • Piper Sandler & Co's Axcelis position peaked at $296K in Q2 2015.
  • 112 funds tracked by Wall St. Rank held Axcelis as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.